Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series

Abstract Background We assessed long-term real-world effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia (HoFH). Methods Retrospective case series of six patients with HoFH treated with lomitapide in an Italian clinic. Changes in low-density lipoprotein c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Patrizia Suppressa, Chiara Coppola, Veronica Cocco, Sallyann O’Brien
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-10-01
coleção:	Orphanet Journal of Rare Diseases
Assuntos:	Homozygous familial hypercholesterolemia Low-density lipoprotein cholesterol Lomitapide Lipid-lowering therapy Apheresis PCSK9 inhibitors
Acesso em linha:	https://doi.org/10.1186/s13023-024-03374-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!